Menu
Cart
Metagenics is a practicioner-only range and can only be supplied in a consultation situation. Please contact us to arrange a phone consultation, or if you already have a consultation password, please enter it below to access all Metagenics products.

Osteo Plus 120tabs

Metagenics

  • 5295


Osteo Plus

120 tablets (30 days)

Hydroxyapatite and Epimedium for Osteoporosis.

Ingredients in Osteo Plus have been shown to or may:

  • Assist in the prevention and treatment of osteoporosis.1
  • Enhance bone mineral density.2
  • Provides extract equivalent to 2.3 g of Epimedium sagittatum.

Clinical Benefits

  • Highly bioavailable calcium: Microcrystalline hydroxyapatite calcium has shown superior performance in maintaining bone density over other forms of calcium including calcium carbonate and calcium gluconate in several clinical trials (Figure One).1,3,4,5 Its clinical success may be associated with the wide range of natural elements present, including trace minerals, amino acids, growth factors (TGF-B and IGF 1 & 2), glycosaminoglycan and type 1 collagen (Figure Two).

Figure One: Calcium Hydroxyapatite and Bone Loss.

Figure One: Calcium Hydroxyapatite and Bone Loss.

Castelo-Branco C, Pons F, Vicente JJ, Sanjuan A, Vanrell JA. Preventing postmenopausal bone loss with osseinhydroxyapatite compounds. Results of a two-year, prospective trial. J Reprod Med 1999;44(7):601-5.

Figure Two: Hydroxyapatite – A Calcium for Building Bones.

Figure Two: Hydroxyapatite – A Calcium for Building Bones.

  • A 4 year cohort study of 112 post-menopausal women measured the efficacy of calcium hydroxyapatite in enhancing bone mineral density.The study reported a progressive and significant increase in bone mineral density of trabecular bone and total bone mass. The mean T-score increased by 33% in trabecular bone, from -1.27 to -0.86 and 69% in total bone mass from -0.67 to -0.21(Figure Three).2

Figure Three: Hydroxyapatite may Enhance Bone Mineral Density.

Figure Three: Hydroxyapatite may Enhance Bone Mineral Density.

Fernandez-Pareja et al. Prevention of Osteoporosis: Four-Year Follow-Up of a Cohort of Postmenopausal Women Treated with an Ossein-Hydroxyapatite Compound. Clin Drug Investig. 2007; 27(4):227-232.

Not all cautions and contraindications are listed. For full details, references or more information contact Health World Limited in Australia on 1800 777 648 or in New Zealand on 0508 227 744.

Directions

Adults: Take 2 tablets twice daily with meals.

Ingredients

Each tablet contains:

 

Extract equivalent to:

 

Epimedium sagittatum, herb top dry

2.3 g

Hydroxyapatite

980.4 mg

Equivalent Calcium

250 mg

Equivalent Phosphorus

107.8 mg

Magnesium oxide

180.7 mg

Equivalent Magnesium

105 mg

Zinc sulfate monohydrate

6.9 mg

Equivalent Zinc

2.5 mg

Borax (Sodium borate)

4.4 mg

Equivalent Boron

500 μg

Manganese sulfate monohydrate

770 μg

Equivalent Manganese

250 μg

Cholecalciferol

2.5 μg

Equivalent Vitamin D3

100 IU

Phytomenadione (Vitamin K1)

2.0 μg

Free from dairy protein, lactose, eggs, nuts, yeast, soy protein and salt. Free from artificial colours and flavours.

 

Storage

Store below 30° C


We Also Recommend
Sale

Unavailable

Sold Out